[1]
Krysanov, I.S., Krysanova, V.S. and Yu, V. 2022. Clinical and Economic Aspects of the First Biosimilar Eculizumab use in Patients with Rare Diseases. Current Trends in Biotechnology and Pharmacy. 16, 2 (May 2022), 223–234. DOI:https://doi.org/10.5530/ctbp.2022.2.21.